KEGG   DRUG: Fezolinetant
Entry
D11976                      Drug                                   
Name
Fezolinetant (USAN);
Veozah (TN)
Product
Formula
C16H15FN6OS
Exact mass
358.1012
Mol weight
358.3933
Structure
Class
Metabolizing enzyme substrate
 DG01892  CYP1A2 substrate
 DG01642  CYP2C9 substrate
 DG01639  CYP2C19 substrate
Remark
ATC code: G02CX06
Product: D11976<US>
Efficacy
Hormone modulator, Tachykinin receptor 3 antagonist
Comment
Treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause
Target
TACR3 (NK3R) [HSA:6870] [KO:K04224]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Metabolism
Enzyme: CYP1A2 [HSA:1544]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 G GENITO URINARY SYSTEM AND SEX HORMONES
  G02 OTHER GYNECOLOGICALS
   G02C OTHER GYNECOLOGICALS
    G02CX Other gynecologicals
     G02CX06 Fezolinetant
      D11976  Fezolinetant (USAN) <US>
USP drug classification [BR:br08302]
 Central Nervous System Agents
  Central Nervous System, Other
   Fezolinetant
    D11976  Fezolinetant (USAN)
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   D11976  Fezolinetant
  DG01642  CYP2C9 substrate
   D11976  Fezolinetant
  DG01639  CYP2C19 substrate
   D11976  Fezolinetant
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Tachykinin
    TACR3 (NK3R)
     D11976  Fezolinetant (USAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11976
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11976
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D11976
Other DBs
CAS: 1629229-37-3
ChEBI: 229236
LinkDB
KCF data

ATOM        25
            1   C8y C    21.7700  -16.3100
            2   C8x C    21.7700  -17.7100
            3   C8x C    20.5800  -18.4100
            4   C8y C    19.3200  -17.7100
            5   C8x C    19.3200  -16.3100
            6   C8x C    20.5800  -15.6100
            7   C5a C    22.9600  -15.6100
            8   N1y N    24.1500  -16.3100
            9   C1x C    25.3400  -15.6100
            10  C1x C    26.6000  -16.3100
            11  N4y N    26.6000  -17.7100
            12  C8y C    25.4100  -18.4100
            13  C1y C    24.1500  -17.7100
            14  O5a O    22.9600  -14.2100
            15  X   F    18.1300  -18.4100
            16  C1a C    22.9600  -18.4100
            17  C8y C    27.5800  -18.6200
            18  N5x N    27.0200  -19.8800
            19  N5x N    25.6900  -19.7400
            20  C8y C    28.9800  -18.3400
            21  N5x N    29.5400  -17.0800
            22  C8y C    30.9400  -17.2200
            23  N5x N    31.2200  -18.5500
            24  S2x S    30.0300  -19.3200
            25  C1a C    31.8500  -16.1700
BOND        28
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14    8  13 1
            15    7  14 2
            16    4  15 1
            17   13  16 1
            18   11  17 1
            19   17  18 2
            20   18  19 1
            21   12  19 2
            22   17  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   23  24 1
            27   20  24 1
            28   22  25 1

» Japanese version   » Back

DBGET integrated database retrieval system